Literature DB >> 11564056

The role of therapeutic drug monitoring in treatment of HIV infection.

D J Back1, S H Khoo, S E Gibbons, C Merry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11564056      PMCID： PMC2014620          DOI： 10.1046/j.1365-2125.2001.0520s1089.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Monitoring therapy.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

2.  Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria.

Authors:  Katherine T Andrews; David P Fairlie; Praveen K Madala; John Ray; David M Wyatt; Petrina M Hilton; Lewis A Melville; Lynette Beattie; Donald L Gardiner; Robert C Reid; Martin J Stoermer; Tina Skinner-Adams; Colin Berry; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  High variability of plasma drug concentrations in dual protease inhibitor regimens.

Authors:  Jean-Baptiste Guiard-Schmid; Jean-Marie Poirier; Jean-Luc Meynard; Philippe Bonnard; Ayi Hola Gbadoe; Corinne Amiel; Frédérique Calligaris; Bruno Abraham; Gilles Pialoux; Pierre-Marie Girard; Patrice Jaillon; Willy Rozenbaum
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

4.  No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.

Authors:  Lynn Purkins; Nolan Wood; Diane Kleinermans; Edward R Love
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

5.  Intracellular and plasma pharmacokinetics of saquinavir-ritonavir, administered at 1,600/100 milligrams once daily in human immunodeficiency virus-infected patients.

Authors:  Jennifer Ford; Marta Boffito; Adrian Wildfire; Andrew Hill; David Back; Saye Khoo; Mark Nelson; Graeme Moyle; Brian Gazzard; Anton Pozniak
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

6.  Protease inhibitor levels in hair strongly predict virologic response to treatment.

Authors:  Monica Gandhi; Niloufar Ameli; Peter Bacchetti; Stephen J Gange; Kathryn Anastos; Alexandra Levine; Charles L Hyman; Mardge Cohen; Mary Young; Yong Huang; Ruth M Greenblatt
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

7.  Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy.

Authors:  Sophie Jose; Killian Quinn; Teresa Hill; Clifford Leen; John Walsh; Phillip Hay; Martin Fisher; Frank Post; Mark Nelson; Mark Gompels; Margaret Johnson; David Chadwick; Richard Gilson; Caroline Sabin; Sarah Fidler
Journal:  AIDS       Date:  2014-06-01       Impact factor: 4.177
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.